HF 448 — A bill for an act relating to the dispensing of self-administered hormonal contraceptives pursuant to a prescription and providing for insurance coverage.

Bill Text

• Introduced View text Current pdf

AI-generated reading aid from the bill's amendatory text — verify against the official bill.

This bill amends existing laws to allow pharmacists to dispense self-administered hormonal contraceptives under specific conditions and provides for insurance coverage of these contraceptives.

• Section 155A.3

  NEW SUBSECTION . 18A. “Generic” means a chemically equivalent copy of a brand-name drug with an expired patent.

  Defines 'Generic' for clarity in the law.

• Section 155A.3

  NEW SUBSECTION . 44A. “Self-administered hormonal contraceptive” means a self-administered hormonal contraceptive that is approved by the United States food and drug administration to prevent pregnancy.

  Defines 'Self-administered hormonal contraceptive' for clarity in the law.

• Section 155A.47

  1. Notwithstanding any provision of law to the contrary, a pharmacist may dispense a self-administered hormonal contraceptive to a patient pursuant to a prescription in accordance with the following: a. For an initial dispensing of a self-administered hormonal contraceptive, the pharmacist may dispense only up to a three-month supply at one time of the self-administered hormonal contraceptive. b. For any subsequent dispensing of the same self-administered hormonal contraceptive, the pharmacist may dispense up to a twelve-month supply at one time of the self-administered hormonal contraceptive.

  Allows pharmacists to dispense self-administered hormonal contraceptives with specific limits on supply.

• Section 155A.47

  2. A pharmacist who dispenses a self-administered hormonal contraceptive in compliance with this section shall be immune from criminal and civil liability arising from any damages caused by the dispensing, administering, or use of a self-administered hormonal contraceptive, provided that the pharmacist acts reasonably and in good faith.

  Provides legal immunity to pharmacists who dispense self-administered hormonal contraceptives under the bill's provisions.

• Section 514C.19

  a. Exclude Such policy, contract, or plan shall not exclude or restrict benefits for prescription contraceptive drugs or prescription contraceptive devices which prevent conception and which are approved by the United States food and drug administration, or generic equivalents approved as substitutable by the United States food and drug administration, if such policy, or contract, or plan provides benefits for other outpatient prescription drugs or devices. → a. Such policy, contract, or plan shall not exclude or restrict benefits for prescription contraceptive drugs or prescription contraceptive devices which prevent conception and which are approved by the United States food and drug administration, or generic equivalents approved as substitutable by the United States food and drug administration, if such policy, or contract, or plan provides benefits for other outpatient prescription drugs or devices. However, such policy, contract, or plan shall specifically provide for payment for a self-administered hormonal contraceptive, as prescribed by a practitioner as defined in section 155A.3, and dispensed by a pharmacist pursuant to section 155A.47, including payment for up to an initial three-month supply of the self-administered hormonal contraceptive dispensed at one time and for up to a twelve-month supply of the same self-administered hormonal contraceptive subsequently dispensed at one time.

  Ensures insurance pays for self-administered hormonal contraceptives and specifies coverage amounts.

Action History

1. February 09, 2021

   Introduced, referred to Human Resources.

Sponsors

• Sunde · Primary

Subjects